| 1. | | Not yet recruiting | 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
| 2. | | Recruiting | Adjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 3. | | Recruiting | Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Gynecologic Malignancy
Conditions: Endocrine Cancer; female reproductive cancer; neurotoxicity |
| 4. | | Recruiting | Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
| 5. | | Recruiting | Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 6. | | Recruiting | Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions: recurrent cervical cancer; cervical adenocarcinoma; cervical adenosquamous cell carcinoma |
| 7. | | Recruiting | Carboplatin Plus Docetaxel and Paclitaxel in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 8. | | Recruiting | Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
Condition: ovarian epithelial cancer |
| 9. | | Not yet recruiting | Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
Conditions: Cervical Cancer; high-grade squamous intraepithelial lesion |
| 10. | | Recruiting | Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 11. | | Not yet recruiting | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
Conditions: squamous cell carcinoma of the vulva; stage III vulvar cancer; stage IV vulvar cancer |
| 12. | | Recruiting | Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Conditions: recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer |
| 13. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Conditions: stage III endometrial cancer; stage IV endometrial cancer; endometrial papillary carcinoma; endometrial clear cell carcinoma |
| 14. | | Recruiting | Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
Conditions: cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; recurrent cervical cancer; ... |
| 15. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Conditions: stage III endometrial cancer; endometrial adenocarcinoma; endometrial adenosquamous cell carcinoma; endometrial adenoacanthoma; ... |
| 16. | | Recruiting | Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
| 17. | | Recruiting | Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
Conditions: recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer |
| 18. | | Recruiting | EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer
Conditions: cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; stage IIB cervical cancer; ... |
| 19. | | Recruiting | Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
| 20. | | Recruiting | Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
Condition: ovarian epithelial cancer |
| 21. | | Recruiting | Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
Conditions: Lymphedema; perioperative/postoperative complications; stage I vulvar cancer; stage II vulvar cancer; stage III vulvar cancer; stage IV vulvar cancer |
| 22. | | Recruiting | Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
Conditions: stage IV endometrial cancer; recurrent endometrial cancer |
| 23. | | Not yet recruiting | Genetic Study in Patients with Advanced Epithelial Ovarian Cancer
Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 24. | | Recruiting | Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Carcinosarcoma
Conditions: uterine carcinosarcoma; recurrent uterine sarcoma |
| 25. | | Recruiting | Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 26. | | Recruiting | Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
Conditions: stage I endometrial cancer; stage II endometrial cancer; endometrial adenocarcinoma; stage I uterine sarcoma; stage II uterine sarcoma |
| 27. | | Recruiting | Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
Conditions: cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; stage I cervical cancer |
| 28. | | Recruiting | Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
Conditions: stage I vulvar cancer; stage II vulvar cancer; squamous cell carcinoma of the vulva |
| 29. | | Recruiting | Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
Condition: Endometrial Cancer |
| 30. | | Recruiting | Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
Conditions: Hydatidiform Mole; uterine choriocarcinoma; nonmetastatic gestational trophoblastic tumor; good prognosis metastatic gestational trophoblastic tumor |
| 31. | | Not yet recruiting | Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 32. | | Recruiting | Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 33. | | Recruiting | Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Condition: ovarian stromal cancer |
| 34. | | Recruiting | Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 35. | | Not yet recruiting | Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
Conditions: recurrent endometrial cancer; endometrial adenocarcinoma; stage III endometrial cancer; stage IV endometrial cancer |
| 36. | | Recruiting | Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
Conditions: cervical squamous cell carcinoma; recurrent cervical cancer; stage III cervical cancer; stage IVA cervical cancer; stage IVB cervical cancer |
| 37. | | Recruiting | Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 38. | | Recruiting | Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer
Conditions: stage 0 cervical cancer; Precancerous Condition |
| 39. | | Not yet recruiting | Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
Conditions: cervical adenocarcinoma; Cervical Cancer; cervical squamous cell carcinoma |
| 40. | | Recruiting | Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
Conditions: stage I uterine sarcoma; stage II uterine sarcoma; stage III uterine sarcoma; stage IV uterine sarcoma; uterine carcinosarcoma |
| 41. | | Recruiting | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer
Condition: Cervical Cancer |
| 42. | | Recruiting | Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer
Condition: Cervical Cancer |
| 43. | | Recruiting | Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer; stage III ovarian epithelial cancer; ... |
| 44. | | Recruiting | Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix
Conditions: stage III cervical cancer; stage IVA cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma; ... |
| 45. | | Recruiting | Screening Study of Surgery and CA 125 Levels in Participants at Increased Genetic Risk of Ovarian Cancer
Condition: ovarian epithelial cancer |
| 46. | | Not yet recruiting | Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 47. | | Recruiting | Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ... |
| 48. | | Not yet recruiting | Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
| 49. | | Recruiting | Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Conditions: stage III endometrial cancer; stage IV endometrial cancer; recurrent endometrial cancer; endometrial adenocarcinoma |
| 50. | | Recruiting | Vaginal Changes and Sexual Function in Patients With Cervical Cancer
Conditions: sexuality and reproductive issues; stage IB cervical cancer |
